Peer-influenced content. Sources you trust. No registration required. This is HCN.

HIT ConsultantIbex’s AI-Powered Cancer Diagnostics Solution Obtains CE Mark

The first standalone AI-based cancer diagnostics product of its kind to receive Vitro Diagnostic Medical Devices Regulation (IVDR) certification is Galen Prostate. Ibex intends to transition more goods, such as its Galen Breast and Galen Gastric solutions, under the IVDR accreditation during 2023.

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form